Overexpression of Alpha2C-adrenoceptors impairs water maze navigation

Neuroscience

Volumn 95, Issue 2, 1999, Pages 481-487

  Bjorklund M ^a   Sirvio J ^a   Riekkinen, M ^a,b   Sallinen, J ^c,d   Scheinin, M ^c   Riekkinen Jr, P ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d ORION CORPORATION   (Finland)

Author keywords

Alpha2C adrenergic receptors; Alpha2C antagonist; Atipamezole; N ethyl 2 bromobenzylamine (DSP 4); Noradrenergic depletion; Search pattern; Spatial navigation

Indexed keywords

ALPHA 2C ADRENERGIC RECEPTOR; ATIPAMEZOLE; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ESCAPE BEHAVIOR; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; MAZE TEST; MOUSE; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RECEPTOR DENSITY; SWIMMING; TRAINING;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BENZYLAMINES; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION; HIPPOCAMPUS; HOMOVANILLIC ACID; IMIDAZOLES; MAZE LEARNING; MICE; MICE, TRANSGENIC; NEUROTRANSMITTER UPTAKE INHIBITORS; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, ALPHA-2; RETENTION (PSYCHOLOGY); SPATIAL BEHAVIOR; SWIMMING;

EID: 0345148339     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00428-5     Document Type: Article

References (46)

1. Abercrombie E.D., Zigmond M.J. Partial injury to central noradrenergic neurons; reduction of tissue norepinephrine content is greater than reduction of extracellular norepinephrine measured by microdialysis. J. Neurosci. 9:1989;4062-4067.
2. Aghajanian G.K., Cedarbaum J.M., Wang R.Y. Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Res. 136:1977;570-577.
3. Arnsten A.F.T., Goldman-Rakic P.S. Alpha-2 adrenergic mechanism in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science. 230:1985;1273-1376.
4. Arnsten A.F.T., Leslie F.M. Behavioural and receptor binding analysis of the α-2 adrenergic agonist, UK-14304 (5 bromo-6 (2-imidazoline-2-yl amino) quinoxaline); evidence for cognitive enhancement at an α-2 adrenoceptor subtype. Neuropharmacology. 30:1991;1279-1289.
5. Barturen F., Garcia-Sevilla J.A. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in rat brain. Molec. Pharmac. 42:1992;846-855.
6. 2C adrenoreceptor antagonist (3H) atipamezole. Eur. J. Pharmac. 224:1992;27-38.
7. 2C-adrenoceptor overexpressing mice are impaired in executing non-spatial and spatial escape strategies. Molec. Pharmac. 54:1998;569-576.
8. Björklund M., Sirviö J., Sallinen J., Scheinin M., Kobilka B., Riekkinen P. Jr. Alpha2C-adrenoceptor overexpression disrupts execution of spatial and non-spatial search patterns. Neuroscience. 88:1999;1187-1198.
9. Bond R.A., Leff P., Johnson T.D., Milano C.A., Rockman H.A., McMinn Th.R., Apparsundaram S., Hyek M.F., Kenakin T.P., et al. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the β Nature. 374:1995;272-276.
10. de Sarro G.B., Ascioti C., Froio F., Libri V., Nistico G. Evidence that locus coeruleus is the site where clonidine and drugs acting at alpha 1- and alpha 2-adrenoceptors affect sleep and arousal mechanisms. Br. J. Pharmac. 90:1987;675-685.
11. Evarts E.V., Wise S.P. Basal ganglia outputs and motor control. Ciba Found. Symp. 107:1984;83-102.
12. Fillenz M. Noradrenergic Neurons. 1990;Cambridge University Press, Cambridge.
13. Fritschy J. M. and Grzanna R. (1991) Selective effects of DSP-4 on locus coeruleus axons: are there pharmacologically different types of noradrenergic axons in the central nervous system. In The neurobiology of Locus Coeruleus, (eds. Barnes C.D. and Pompeiano O.). Elsevier, Amsterdam.
14. Gobert B., Rivet A., Cistarelli J.M., Melon C., Millan M.J. Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats. J. Neurochem. 69:1997;2616-2619.
15. Jäkälä P., Sirviö J., Jolkkonen J., Riekkinen P. Jr., Acsady L., Riekkinen P. The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. Behav. Brain Res. 51:1992;29-40.
16. Kety S. S. (1970) The biogenic amines and the central nervous system: their possible roles in arousal, emotion and learning. In The Neurosciences, (ed. Schmidt F. O.), Second Study Program. Rockefeller UP, New York.
17. 2-adrenergic receptor. Science. 238:1987;650-656.
18. 2-adrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system. Neuroscience. 84:1998;1085-1096.
19. 2-C10 homolog responsible for an interspecies variation in antagonist binding. Molec. Pharmac. 42:1992;16-27.
20. 2-adrenergic receptor subtype, the gene which is located on chromosome 2. Proc. Natn. Acad. Sci. U.S.A. 87:1990;5094-5098.
21. 2-adrenoceptor-subtype function. Trends. pharmac. Sci. 18:1997;211-219.
22. MacDonald E., Scheinin M. Distribution and pharmacology of alpha 2-adrenoceptors in the central nervous system. J. Physiol. Pharmac. 46:1995;241-258.
23. McCormick D.A., Pape H.C., Williamson A. Actions of norepinephrine in the cerebral cortex and thalamus: implications for function of the central noradrenergic system. Prog. Brain Res. 88:1991;293-305.
24. Morris R.G M. Developments of a water-maze procedure for studying spatial learning in rats. J. Neurosci. Methods. 11:1984;47-60.
25. Morris R.G., Hagan J.J., Rawlins J.N. Allocentric spatial learning by hippocampectomised rats: a further test of the "spatial mapping" and "working memory" theories of hippocampal function. J. Expl. Psychol. B. 38:1986;365-395.
26. Nicholas A.P., Hökfelt T., Pieribone V.A. The distribution and significance of CNS adrenoceptors examined with in situ hybridization. Trends. Pharmac. Sci. 17:1996;245-255.
27. Nicholas A.P., Pieribone V., Hökfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. comp. Neurol. 328:1993;575-594.
28. Puumala T., Björklund M., Ruotsalainen S., Riekkinen M., Jäkälä P., Haapalinna A., Björk E., Riekkinen P., Sirviö J. Lack of relationship between thalamic oscillations and attention in rats: differential modulation by an alpha-2 antagonist. Brain Res. Bull. 43:1997;163-171.
29. 2-adrenergic receptor subtype. Proc. natn. Acad. Sci. U.S.A. 85:1988;6301-6305.
30. alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes. J. Pharmac. Expl. Ther. 270:1994;946-957.
31. Riekkinen M., Kemppainen S., Riekkinen P. Effects of stimulation of alpha 1-adrenergic and NMDA/glycine-B receptors on learning defects in aged rats. Psychopharmac. Berl. 131:1997;49-56.
32. 2 antagonist and agonist on EEG slowing induced by scopolamine and lesion of the nucleus basalis. Neuropharmacology. 29:1990;993-999.
33. 2C-adrenergic receptor like immunoreactivity in the rat central nervous system. J. comp. Neurol. 372:1996;135-165.
34. Sahakian B.J., Coull J.T., Hodges J.R. Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type. J. Neurol. Neurosurg. Psychiatry. 57:1994;120-121.
35. Sallinen J., Link R.E., Haapalinna A., Viitamaa T., Kulatunga M., Sjöholm B., MacDonald E., Pelto-Huikko M., Leino T., et al. Genetic alteration of alpha-2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha-2-adrenoceptor agonist. Molec. Pharmac. 51:1997;39-46.
36. Samama P., Bond R.A., Rockman H.A., Milano C.A., Lefkowitz R.J. Ligand-induced overexpression of a constitutively active beta2-adrenergic receptor: pharmacological creation of a phenotype in transgenic mice. Proc. natn. Acad. Sci. U.S.A. 94:1997;137-141.
37. Sara S.J., Vankov A., Herve A. Locus coeruleus-evoked responses in behaving rats: a clue to the role of noradrenaline in memory. Brain Res. Bull. 35:1994;457-465.
38. 2-adrenoceptor antagonist. Eur. J. Pharmac. 151:1988;35-42.
39. Scheinin M., Lomasney J.W., Hayden-Hixson D.M., Schambra U.B., Caron M.G., Lefkowitz R.J., Fremeau R.T. Jr. Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain. Brain Res. Molec. Brain Res. 21:1994;133-149.
40. 2 agonist, on learning and memory, assessed using passive avoidance and water maze tasks in rats. Neuropharmacology. 31:1992;163-168.
41. 2A-adrenergic receptor like immunoreactivity in the rat central nervous system. J. comp. Neurol. 372:1996;111-134.
42. Uhlen S., Lindblom J., Tiger G., Wikberg J.E. Quantification of alpha 2A and 2C adrenoceptors in in the rat striatum and in different regions of the spinal cord. Acta physiol. Scand. 160:1997;407-412.
43. 2-adrenoceptors by atipamezole. Arch. int. Pharmacodyn. Thér. 297:1989;190-204.
44. Whishaw I.Q. Dissociating performance and learning deficits on spatial navigation tasks in rats subjected to cholinergic muscarinic blockade. Brain Res. Bull. 23:1989;347-358.
45. Wolfer D.P., Stagljar-Bozicevic M., Errington M.L., Lipp H.-P. Spatial memory and learning in transgenic mice: fact or artefact? News Physiol. Sci. 13:1998;118-123.
46. 2C Adrenoceptors inhibit adenyl cyclase in mouse striatum: Potential activation by dopamine. J. Pharmac. exp. Ther. 289:1999;1286-1292.